Anticoagulant Use and Risk of Ischemic Stroke and Bleeding in Patients With Secondary Atrial Fibrillation Associated With Acute Coronary Syndromes, Acute Pulmonary Disease, or Sepsis

JACC: Clinical Electrophysiology

Volumn 4, Issue 3, 2018, Pages 386-393

  Quon, Michael J ^a   Behlouli, Hassan ^a   Pilote, Louise ^a,b  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

cerebrovascular accident; myocardial infarction; new onset; warfarin

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; APIXABAN; CLOPIDOGREL; DABIGATRAN; RIVAROXABAN; WARFARIN;

ACUTE CORONARY SYNDROME; ACUTE DISEASE; AGED; ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; BLEEDING; BRAIN ISCHEMIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; DISEASE ASSOCIATION; DRUG USE; DUAL ANTIPLATELET THERAPY; FEMALE; FOLLOW UP; HOSPITAL DISCHARGE; HUMAN; INFLUENZA; LUNG DISEASE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; NEW-ONSET ATRIAL FIBRILLATION; PLEURA EFFUSION; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEPSIS; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; COMORBIDITY; COMPLICATION; INCIDENCE; RISK FACTOR; THROMBOSIS; VERY ELDERLY;

ACUTE CORONARY SYNDROME; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; COMORBIDITY; FEMALE; HEMORRHAGE; HUMANS; INCIDENCE; LUNG DISEASES; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; SEPSIS; STROKE; THROMBOSIS;

EID: 85030693908     PISSN: 2405500X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacep.2017.08.003     Document Type: Article

References (21)

1. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 154 (1994), 1449–1457.
2. Fuster, V., Rydén, L.E., Cannom, D.S., et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force of Practice Guidelines. J Am Coll Cardiol 57 (2011), e100–e198.
3. Lubitz, S.A., Yin, X., Rienstra, M., et al. Long-term outcomes of secondary atrial fibrillation in the community: the Framingham Heart Study. Circulation 131 (2015), 1648–1655.
4. Walkey, A.J., Wiener, R.S., Ghobrial, J.M., et al. Incident stroke and mortality associated with new-onset atrial fibrillation in patients hospitalized with severe sepsis. JAMA 306 (2011), 2248–2254.
5. Walkey, A.J., Hammill, B.G., Curtis, L.H., et al. Long-term outcomes following development of new-onset atrial fibrillation during sepsis. Chest 146 (2014), 1187–1195.
6. Walkley, A., Quinn, E., Winter, M., et al. Practice patterns and outcomes associated with use of anticoagulation among patients with atrial fibrillation during sepsis. JAMA Cardiol 1 (2016), 682–690.
7. Mehta, R.H., Dabbous, O.H., Granger, C.B., et al. Comparison of outcomes of patients with acute coronary syndromes with and without atrial fibrillation. Am J Cardiol 92 (2003), 1031–1036.
8. Lopes, R.D., Elliott, L.E., White, H.D., et al. Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial. Eur Heart J 30 (2009), 2019–2028.
9. Siu, C.W., Jim, M.H., Ho, H.H., et al. Transient atrial fibrillation complicating acute inferior myocardial infarction: implications for future risk of ischemic stroke. Chest 132 (2007), 44–49.
10. Zusman, O., Amit, G., Gilutz, H., et al. The significance of new onset atrial fibrillation complicating acute myocardial infarction. Clin Res Cardiol 101 (2012), 17–22.
11. Asanin, M.R., Vasiljevic, Z.M., Matic, M.D., et al. The long-term risk of stroke in patients with acute myocardial infarction complicated with new-onset atrial fibrillation. Clin Cardiol 32 (2009), 467–470.
12. Atzema, C.L., Lam, K., Young, C., et al. Patients with atrial fibrillation and an alternative primary diagnosis in the emergency department: a description of their characteristics and outcomes. Acad Emerg Med 20 (2013), 193–199.
13. January, C.T., Wann, L.S., Alpert, J.S., et al. 2014 AHA/ACC/HRS Guideline for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. J Am Coll Cardiol 130 (2014), 199–267.
14. Camm, A.J., Kirchhof, P., Lip, G.Y., et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace 12 (2010), 1360–1420.
15. Cairns, J.A., Connolly, S., McMurtry, S., et al., CCS Atrial Fibrillation Guidelines Committee. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter. Can J Cardiol 27 (2011), 74–90.
16. Macle, L., Cairns, J., Leblanc, K., et al. 2016 focused update of the Canadian Cardiovascular Society Guidelines for the management of atrial fibrillation. Can J Cardiol 32 (2016), 1170–1185.
17. Tsadok, M.A., Jackevicius, C.A., Essebag, V., et al. Rhythm versus rate control therapy and subsequent stroke or transient ischemic attack in patients with atrial fibrillation. Circulation 126 (2012), 2680–2687.
18. Shah, M., Tsadok, M.A., Jackevicius, C.A., et al. Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis. Circulation 129 (2014), 1196–1203.
19. Avgil Tsadok, M.A., Jackevicius, C.A., Rahme, E., et al. Sex differences in stroke risk among older patients with recently diagnosed atrial fibrillation. JAMA 307 (2012), 1952–1958.
20. Friberg, L., Rosenqvist, M., Lip, G.Y., Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study. Circulation 125 (2012), 2298–2307.
21. Tsadok, M., Jackevicius, C., Essebag, V., Warfarin treatment and outcomes of patients with atrial fibrillation in rural and urban setting. J Rural Health 31 (2015), 310–315.